Nordea Investment Management Ab Seagen Inc. Transaction History

Nordea Investment Management Ab

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$191.51 - $216.16 $112,990 - $127,534	590 Added 6.75%	9,331 $1.98 Million
Q4 2022 Feb 08, 2023	BUY	$117.37 - $139.17 $43,192 - $51,214	368 Added 4.4%	8,741 $1.12 Million
Q2 2022 Aug 09, 2022	BUY	$108.81 - $179.33 $131,877 - $217,347	1,212 Added 16.93%	8,373 $1.49 Million
Q3 2021 Nov 01, 2021	SELL	$142.45 - $169.82 $1.02 Million - $1.22 Million	-7,161 Reduced 50.0%	7,161 $1.19 Million
Q3 2021 Nov 01, 2021	BUY	$142.45 - $169.82 $1.02 Million - $1.22 Million	7,161 Added 100.0%	14,322 $2.43 Million

Q2 2021 Jul 16, 2021	BUY	$135.08 - $161.1 $166,283 - $198,314	1,231 Added 20.76%	7,161 $1.13 Million
Q1 2021 May 17, 2021	SELL	$137.51 - $190.8 $44,415 - $61,628	-323 Reduced 5.17%	5,930 $822,000
Q4 2020 Feb 12, 2021	BUY	$164.63 - $211.93 $1.03 Million - $1.33 Million	6,253 New	6,253 $1.1 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

Stay updated on Nordea Investment Management Ab with notifications on news.